BanwellBKennedyJSadovnickD. Incidence of acquired demyelination of the CNS in Canadian children. Neurology2009; 72: 232–239.
2.
AbsoudMLimMJChongWK. Paediatric acquired demyelinating syndromes: Incidence, clinical and magnetic resonance imaging features. Mult Scler2012; 19: 76–86.
3.
KetelslegersIACatsman-BerrevoetsCENeuteboomRF. Incidence of acquired demyelinating syndromes of the CNS in Dutch children: A nationwide study. J Neurol2012; 259: 1929–1935.
4.
ChitnisTTenembaumSBanwellB. Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler2012; 18: 116–127.
5.
GormanMHealyBPolgar-TurcsanyiM. Relapses are more frequent in pediatric-onset than adult-onset multiple sclerosis. Mult Scler2008; 14: S66.
6.
RenouxCVukusicSMikaeloffY. Natural history of multiple sclerosis with childhood onset. N Engl J Med2007; 356: 2603–2613.
7.
GhassemiRNarayananSBanwellB. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PLoS ONE2014; 9: e85741.
8.
VerheyLHSignoriAArnoldDL. Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology2013; 81: 1215–1221.
